Ondine Biomedical Inc. (AIM:OBI)
London
· Delayed Price · Currency is GBP · Price in GBX 13.84
+0.09 (0.65%)
Jul 8, 2025, 12:38 PM GMT+1
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 60.97 million as of July 8, 2025. Its market cap has increased by 166.53% in one year.
Market Cap
60.97M
Enterprise Value
55.64M
Revenue
1.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.84
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 60.97M, a decrease of -45.98%. That is a compound annual growth rate of -15.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 4, 2025 | 63.19M | 77.72% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.45B |
| GSK plc | 56.46B |
| Haleon | 33.36B |
| Smith & Nephew | 9.70B |
| ConvaTec Group | 5.40B |
| Hikma Pharmaceuticals | 4.37B |
| HUTCHMED (China) | 1.93B |
| Indivior | 1.40B |